Autoimmunity as an aetiological factor in vitiligo.
Vitiligo is a common dermatological disorder characterized by the presence on the skin of depigmented macules resulting from the destruction of cutaneous melanocytes. Autoimmunity is an important hypothesis with regard to vitiligo aetiology and the evidence for autoimmune responses being involved in the pathogenesis of this disorder will be discussed in the present review. All immune system compartments, including innate and adaptive immunity have been implicated in vitiligo development. Particularly relevant are autoantibodies and autoreactive T cells in vitiligo patients that have cytotoxic effects upon pigment cells. Furthermore, predisposition to vitiligo appears to be associated with certain alleles of the major histocompatibility complex class II antigens as well as with other autoimmune-susceptibility genes. Moreover, the association of vitiligo with autoimmune disorders, the animal models of the disease, and the positive response to immunosuppressive therapeutic agents emphasize the role of autoimmunity in the development of this disorder.
Rezaei
N
N
Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Gavalas
N G
NG
Weetman
A P
AP
Kemp
E H
EH
D000818:Animals; D001323:Autoantibodies / Q000096:biosynthesis; D001327:Autoimmune Diseases / Q000150:complications; D015551:Autoimmunity; D004195:Disease Models, Animal; D006801:Humans; D007111:Immunity, Cellular; D007125:Immunogenetics; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008544:Melanocytes / Q000276:immunology; D008545:Melanoma / Q000150:complications / Q000276:immunology; D012878:Skin Neoplasms / Q000150:complications / Q000276:immunology; D014820:Vitiligo / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*
D001323:Autoantibodies; D007166:Immunosuppressive Agents